PSA Test - More Harm Than Good For Prostate Cancer Screening

Thursday, January 1, 2015 - 20:00 in Health & Medicine

New prostate screening guidelines recommend that the prostate-specific antigen (PSA) test not be used to screen for prostate cancer based on evidence that shows uncertain benefits and   an increased risk of harm.  Prostate cancer is the most commonly diagnosed non-skin cancer in men and the third most common cause of death from cancer in men in Canada and elsewhere. In modern times, the prognosis for most prostate cancers is good with a 10-year survival rate of 95%. Prostate cancer is generally slow to progress and today is usually not life-threatening.  read more

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net